Drug Information

Drug General Information
Drug ID
D0A9UF
Former ID
DNC013487
Drug Name
1,2,3,7,12,12a-hexahydro-1-aza-pleiaden-5-ol
Drug Type
Small molecular drug
Indication Discovery agent Investigative [528616]
Structure
Download
2D MOL

3D MOL
Formula
C17H17NO
Canonical SMILES
C1CNC2CC3=CC=CC=C3CC4=CC(=CC1=C24)O
InChI
1S/C17H17NO/c19-15-8-13-5-6-18-16-10-12-4-2-1-3-11(12)7-14(9-15)17(13)16/h1-4,8-9,16,18-19H,5-7,10H2
InChIKey
ZCATUTKNMGBMKU-UHFFFAOYSA-N
PubChem Compound ID
44448059
Target and Pathway
Target(s) Dopamine D1 receptor Target Info Inhibitor [528616]
KEGG Pathway Calcium signaling pathway
cAMP signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Dopaminergic synapse
Parkinson's disease
Cocaine addiction
Amphetamine addiction
Morphine addiction
Alcoholism
PANTHER Pathway Dopamine receptor mediated signaling pathway
PathWhiz Pathway Dopamine Activation of Neurological Reward System
Reactome Dopamine receptors
G alpha (s) signalling events
WikiPathways Hypothetical Network for Drug Addiction
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Genes and (Common) Pathways Underlying Drug Addiction
GPCR ligand binding
GPCR downstream signaling
References
Ref 528616J Med Chem. 2007 Jan 25;50(2):171-81.Advances in development of dopaminergic aporphinoids.
Ref 528616J Med Chem. 2007 Jan 25;50(2):171-81.Advances in development of dopaminergic aporphinoids.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.